Glenmark Pharma Q1 PAT seen up 23.3% YoY to Rs 313.1 cr: KRChoksey

KRChoksey has come out with its first quarter (April-June’ 21) earnings estimates for the Pharma sector. The brokerage house expects Glenmark Pharma to report net profit at Rs 313.1 crore up 23.3% year-on-year.

Net Sales are expected to increase by 23.1 percent Y-o-Y (up 1 percent Q-o-Q) to Rs 2,887 crore, according to KRChoksey.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 32.3 percent Y-o-Y to Rs 632.3 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.